ARCHIVES

Pharmacogenomics May Lead To Individualized Treatment

This article is from The Cancer Letter archive.

Vol. 27 No. 6 | June 25, 2004

Download PDF Visit The Full Archive

Related Articles

NCI Backed Studies Indicate Overweight Not Much Of a Cancer Risk Factor

June 19, 1987

In Brief: Control Grant Review committee Out Of Grants Division Provisional Training Announcement Due

October 10, 1975

Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent

January 27, 2012

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

April 26, 1996

Hormone Therapy Can Reduce Survival In Men With Heart Problems

August 26, 2011

Also in This 8-page Issue: President Bush Nominates EPA Administrator Michael Leavitt for HHS Secretary.

January 7, 2005